ReviewJournal of clinical medicine2020

Current Treatment Options for Chronic Myeloid Leukemia Patients Failing Second-Generation Tyrosine Kinase Inhibitors.

Valentín García-Gutiérrez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.